ANNMARIE REED: Open Payments
NPI 1235520842 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 18 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $510 · 2025 $904
Food & beverage: $904
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $387 |
| E.R. Squibb & Sons, L.L.C. | 4 | $297 |
| ABBVIE INC. | 5 | $149 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
Products named: COBENFY, ABILIFY MAINTENA, VRAYLAR, REXULTI, CAPLYTA, ABILIFY ASIMTUFII, TRINTELLIX.
Industry payments across ID — which companies pay providers there.
